Browse by topics
THE BIG READ
Serán Bioscience Secures Investment to Expand Commercial Manufacturing
4 min read • 4 weeks ago
The investment, led by Biospring Partners, will support Serán Bioscience’s expansion into commercial-scale production and state-of-the-art manufacturing facilities in Bend, Oregon.
-
Expansion
Circio Raises Funds to Advance in vivo CAR-T Program
The Norwegian biotech plans to use the raised capital to expand its circular RNA platform and secure complementary…
-
Expansion
Northway Biotech Expands CGMP Cell-Based Manufacturing
The Lithuanian CDMO has opened a new facility in Vilnius that can support advanced and personalized therapies, including…
-
Expansion
Codis Expands European Footprint with Catalent Nottingham Facility Acquisition
By combining Nottingham’s development capabilities with its expanded Haverhill site, Codis creates an integrated UK pathway spanning early-stage…
THE BIG READ
Nanoform Highlights CESS Benefits Versus Spray-Dried ASDs
1 month ago
According to the company, its commercial-scale nanoparticle manufacturing technology could reduce production costs and solvent use while increasing drug loading.
-
Discovery & Development
Moonwalk Biosciences Closes Oversubscribed Series B Financing Round
The company has managed to raise USD 70 million, which it will use to progress its lead candidate…
-
Discovery & Development
MedPharm Gains Olink Certification to Introduce Proteomic Analysis Services
Through this certified status, the CDMO will be able to offer its customers targeted, multiplex protein biomarker analysis…
-
Discovery & Development
EyePoint Positions DURAVYU as a Potential Treatment for Wet AMD
Although the trial did not meet its primary endpoint, EyePoint reported a 42% reduction in overall treatment burden,…
THE BIG READ
Bridging the Pipeline Gap
5 min read • 4 weeks ago
With the rise of increasingly complex biologics, innovators are leaning toward specialized service providers to bridge the gap between early breakthrough science and commercial manufacturing reality.
-
Discovery & Development
CPHI Milan 2026: Connecting Supply Chains, Digital Innovations, and Sustainability
Ahead of CPHI Milan, Event Director Tara Dougal shares insights on the key themes, new dedicated zones, and…
-
Discovery & Development
CPHI Milan 2026: Balancing Viscosity, Compliance, and Sustainability in Fill/Finish
Ahead of CPHI Milan 2026, Professor Hanns-Christian Mahler from ten23 health, explores how expanding dose volumes, flexible CDMO…
-
Discovery & Development
CPHI Milan 2026: Overcoming Formulation Barriers in LAIs
As demand for patient-centric chronic disease treatments grows, Nanexa CTO Mårten Rooth discusses how atomic layer deposition enables…
THE BIG READ
Lifecore Biomedical Signs Major Commercial Site-Transfer Deal
1 month ago
The Minnesota injectables CDMO has signed a technical transfer and manufacturing agreement for a currently marketed, high-viscosity injectable, marking its seventh late‑stage commercial program and 11th pipeline addition…
-
Dealmaking
Novo Nordisk Secures Global License to Nanexa’s ALD Drug Delivery Platform
A global licensing agreement worth up to EUR 1.165 billion will leverage Nanexa's PharmaShell technology to develop long-acting…
-
Dealmaking
Lifecore Biomedical Signs Major Commercial Site-Transfer Deal
The Minnesota injectables CDMO has signed a technical transfer and manufacturing agreement for a currently marketed, high-viscosity injectable,…
-
Dealmaking
Lilly to Acquire Merida Biosciences for Antibody-Degradation Technology
Through this acquisition, Eli Lilly will strengthen its immunology capabilities by gaining access to a first-in-class antibody-degradation platform…
THE BIG READ
Roche Gets Nod from European Commission for Susvimo
1 month ago
The European Commission has approved the ranibizumab 100 mg/mL injectable solution (Susvimo) from Roche as a treatment of neovascular age-related macular degeneration.
-
Regulatory
Camizestrant Combination for Metastatic Breast Cancer Gains FDA Approval
The U.S. regulatory body has approved AstraZeneca’s Etcamah in combination with CDK4/6 inhibitors, to treat adults with HR‑positive,…
-
Regulatory
Weekly HIV Pill Advances Toward Regulatory Submission
A combination therapy from Gilead and Merck has met its clinical efficacy endpoint, demonstrating non-inferiority to existing daily…
-
Regulatory
FDA Extends Review of AstraZeneca’s Camizestran
AstraZeneca’s camizestrant has faced a regulatory setback in the U.S., with the FDA extending its review, seeking clearer…
THE BIG READ
Codis Appoints Steven Facer in New Role as Chief Commercial Officer
1 month ago
The newly created role will bring the CDMO’s sales, marketing, and business development teams under a unified commercial strategy across the U.S. and UK.
-
Funding & Investments
Building a Value-Driven Platform
SPONSORED CONTENT: As the biopharmaceutical landscape increasingly demands integrated technical operations, GCCs are expanding beyond back-office efficiency, reveals…
-
Funding & Investments
Closing the Bioprocessing Gap
As the divide between upstream output and downstream capability in bioprocessing expands, it is becoming necessary for the…
-
Funding & Investments
Overcoming the Hurdles to Oral Peptide Development
Experts from Alcami break down the latest innovations in lipid-based permeation matrices, continuous direct compression, and advanced analytical…
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.
Adalvo Targets Complex Medicines with Romiplostim Biosimilar Deal
Manufacturing & OperationsRegulatory & ComplianceSterile/Aseptic
Right-Sized Contamination Control: Annex 1 Compliance for Small Enclosures 1 day ago
Charting the Best CourseDiscovery & DevelopmentEarly Phase
Tailoring Partnerships for Lean Sponsors 6 days agoTrending Stories
-
Formulation ServicesManufacturing ServicesOutsourcing & Partnerships
Adalvo Targets Complex Medicines with Romiplostim Biosimilar Deal -
Manufacturing & OperationsRegulatory & ComplianceSterile/Aseptic
Right-Sized Contamination Control: Annex 1 Compliance for Small Enclosures -
Analytical ServicesDiscovery & DevelopmentEarly Phase
Navigating the Inflection Point -
Charting the Best CourseDiscovery & DevelopmentEarly Phase
Tailoring Partnerships for Lean Sponsors -
Discovery & DevelopmentOutsourcing & Partnerships
METiS and Lilly Partner to Develop AI-Designed, Tissue-Targeted LNPs -
Regulatory & ComplianceU.S.
GSK Wins FDA Approval for its Locally Advanced Rectal Cancer Immunotherapy
Multimedia Insights
Breaking Down Silos with a Science-First Platform
08:12 mins • 2 weeks ago
Bridging the Solubility Barrier with Bile Acids
08:12 mins • 4 months ago
Putting Clinical Trials Under a Magnifying Glass
08:12 mins • 6 months ago
ATMPs: At the Precipice of Success or Failure
08:12 mins • 7 months ago
Outsourcing & Partnerships
- Adalvo Targets Complex Medicines with Romiplostim Biosimilar Deal 1 day ago
- Navigating the Inflection Point 4 days ago
- Tailoring Partnerships for Lean Sponsors 6 days ago
Strategy & Business
Manufacturing & Operations
Regulatory & Compliance
Discovery & Development
Multimedia & Events
- Bridging the Solubility Barrier with Bile Acids 4 months ago
- Putting Clinical Trials Under a Magnifying Glass 6 months ago
- ATMPs: At the Precipice of Success or Failure 7 months ago
Upcoming Events
The Advanced Therapies Congress is America's most exciting cell and gene therapy conference and exhibition.
Bringing together innovative minds, visionary leaders, and industry business tycoons to discuss and explore key highlights across the world of Pharma-Supply Chain & Logistics. PPSL is a creative & leading industry platform to connect with the key influential leaders of the industry.
MEDICA brings together international stakeholders from medicine, technology, industry, and policymaking.
Network with 1,500+ colleagues at the largest protein & antibody engineering event in Europe, which has also been described as "the best biologics technology meeting in Europe."
